1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rubbing out leukemia stem cells by erasing the eraser
    Journal Article

    Cheng, Y.; Luo, H.; Kharas, M. G.
    Cell Stem Cell (2020)

    Fulltext@MSK | Save
  • Loss of TET2 affects proliferation and drug sensitivity through altered dynamics of cell-state transitions
    Journal Article

    Morinishi, L.; Kochanowski, K.; Levine, R. L.; Wu, L. F.; Altschuler, S. J.
    Cell Systems (2020)

    Fulltext@MSK | Save
  • SF3B1-mutant MDS as a distinct disease subtype: A proposal from the International Working Group for the Prognosis of MDS
    Guidelines

    Malcovati, L.; Stevenson, K.; Papaemmanuil, E.; Neuberg, D.; Bejar, R.; Boultwood, J.; Bowen, D. T.; Campbell, P. J.; Ebert, B. L.; Fenaux, P.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Leukemia secondary to myeloproliferative neoplasms
    Journal Article

    Dunbar, A. J.; Rampal, R. K.; Levine, R.
    Blood (2020)

    Fulltext@MSK | Save
  • Targetable micropharmacies: Cells that produce small-molecule drugs in situ at the tumor site
    Meeting Abstract

    Gardner, T. J.; Lee, P.; Wijewarnasuriya, D.; Kinarivala, N.; Bourne, C.; Kurtz, K.; Corless, B.; Dacek, M.; Mo, G.; Brentjens, R.; more...
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Mechanisms of adoptive T cell micropharmacies
    Meeting Abstract

    Bourne, C.; Gardner, T.; Romero-Pichardo, J.; Lee, P.; Dacek, M.; Tan, D.; Scheinberg, D.
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Genomic alterations in colitis-associated cancers in comparison to those found in sporadic colorectal cancer and present in precancerous dysplasia
    Meeting Abstract

    Chatila, W. K.; Walch, H. S.; Benhamida, J.; Hechtman, J. F.; Barriga, F. M.; Kundra, R.; Ismalgeci, D.; Miller, V. A.; Ganesh, K.; Faleck, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic correlates of extreme pathologic response following neoadjuvant chemotherapy in locally advanced gastric cancer to reveal distinct vulnerabilities
    Meeting Abstract

    Datta, J.; Walch, H. S.; Russo, A.; Chatila, W. K.; Vos, E.; Bhanot, U.; Janjigian, Y. Y.; Schultz, N.; Tang, L. H.; Strong, V. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic characterization of rectal cancer and molecular determinants of response to neoadjuvant chemoradiotherapy
    Meeting Abstract

    Chatila, W. K.; Marco, M.; Qu, X.; Walch, H. S.; Luthra, A.; Chen, C. T.; Kundra, R.; Schultz, N.; Yaeger, R.; Smith, J. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Treatment with banked 3rd party donor derived virus specific T cells: The advantages of pre-defined HLA restriction and epitope specificity
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; O'Reilly, R. J.
    Cytotherapy (2020)

    Fulltext@MSK | Save